Evidence map›Paper›PMID 38646431›Full record

ArticleFrontiers in oncology2024

Case report: Navigating treatment pathways for cardiac intimal sarcoma with

Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Koushiro Ohtsubo, Keishi Mizuguchi, Hiroko Ikeda, Kenji Iino, Hirofumi Takemura and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Akihiro NishiyamaDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Shigeki SatoDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Hiroyuki SakaguchiDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Hiroshi KotaniDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Kaname YamashitaDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Koushiro OhtsuboDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Keishi MizuguchiDepartment of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
Hiroko IkedaDepartment of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
Kenji IinoDepartment of Cardiovascular Surgery, Kanazawa University, Kanazawa, Japan.
Hirofumi TakemuraDepartment of Cardiovascular Surgery, Kanazawa University, Kanazawa, Japan.
Shinji TakeuchiDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
Kanazawa University Hospital · JPKanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the realm of rare cardiac tumors, intimal sarcoma presents a formidable challenge, often requiring innovative treatment approaches. This case report presents a unique instance of primary intimal sarcoma in the left atrium, underscoring the critical role of genomic profiling in guiding treatment. Initial genomic testing unveiled a somatic, active mutation in

Indexed as

CDK4 amplificationintimal sarcomaMDM2 amplificationPDGFRβ N666K mutationprecision oncology

Identifiers

PMID38646431
PMCPMC11026546
OpenAlexW4393987256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.